ETF Managers Group, LLC Galmed Pharmaceuticals Ltd. Transaction History

ETF Managers Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.06 - $4.17 $222,278 - $302,908	-72,640 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.46 - $5.69 $19,545 - $32,142	5,649 Added 8.43%	72,640 $254,000
Q2 2020 Aug 14, 2020	BUY	$3.22 - $6.08 $81,926 - $154,693	25,443 Added 61.24%	66,991 $324,000
Q1 2020 May 14, 2020	BUY	$3.3 - $6.84 $12,183 - $25,253	3,692 Added 9.75%	41,548 $143,000
Q4 2019 Feb 14, 2020	SELL	$3.61 - $6.75 $32,049 - $59,926	-8,878 Reduced 19.0%	37,856 $216,000
Q3 2019 Nov 14, 2019	BUY	$4.62 - $7.11 $6,985 - $10,750	1,512 Added 3.34%	46,734 $228,000
Q2 2019 Aug 14, 2019	BUY	$5.68 - $8.68 $66,166 - $101,113	11,649 Added 34.7%	45,222 $282,000
Q1 2019 May 07, 2019	SELL	$7.27 - $9.07 $7,873 - $9,822	-1,083 Reduced 3.13%	33,573 $274,000
Q4 2018 Feb 01, 2019	BUY	$6.59 - $14.47 $75,007 - $164,697	11,382 Added 48.9%	34,656 $237,000
Q3 2018 Nov 14, 2018	BUY	$10.55 - $15.28 $245,540 - $355,626	23,274 New	23,274 $316,000
Q2 2018 Aug 14, 2018	SELL	$5.04 - $17.96 $75,942 - $270,621	-15,068 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.12 - $11.77 $12,354 - $28,401	2,413 Added 19.07%	15,068 $76,000
Q4 2017 Feb 14, 2018	BUY	$6.78 - $9.32 $85,800 - $117,944	12,655	12,655 $119,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $153M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.